Responses
Oncolytic and local immunotherapy
Original research
Combination of oncolytic Maraba virus with immune checkpoint blockade overcomes therapy resistance in an immunologically cold model of advanced melanoma with dysfunctional T-cell receptor signalling
Compose a Response to This Article
Other responses
No responses have been published for this article.